menu
    • menu

    List of Certificates of Suitability (CEPs) for Active Pharmaceutical Ingredients (APIs) issued to Bayer AG by EDQM. Original Data: EDQM Database

    lebsa-m-2024-10-21

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    For over a century, Bayer has stood for improving everyday health and wellness for millions of consumers worldwide. People everywhere make Bayer a trusted part of their daily lives. This deep connection with consumers has fueled the growth and innovation of our product portfolio and we believe that our brands will continue to play a critical role in the health and welfare of people worldwide. Our rich history began in 1897 wit...
    For over a century, Bayer has stood for improving everyday health and wellness for millions of consumers worldwide. People everywhere make Bayer a trusted part of their daily lives. This deep connection with consumers has fueled the growth and innovation of our product portfolio and we believe that our brands will continue to play a critical role in the health and welfare of people worldwide. Our rich history began in 1897 with the synthesis of a stable form of acetylsalicylic acid (ASA), which was introduced to the market as Aspirin™ in 1899. In 1969, Aspirin made it to the moon aboard the Apollo 11 and by the mid-1980’s.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Bayer AGGermany Flag
    Country
    Country
    Germany
    Address
    Address
    Mullerstr. 178, 13353 Berlin
    Telephone
    Telephone
    +49 30 468 1111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://pharma.bayer.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    CPhI India 2024

    CPhI India 2024

    Not Confirmed

    envelop Contact Supplier

    CPhI India 2024

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We have built considerable expertise in GLP-1 drug development through our oral peptide programs”

    “We have built considerable expertise in GLP-1 drug development through our oral peptide programs”

    This week, Speak Pharma interviews Dr. Andrew Lewis, Chief Scientific Officer at Quotient Sciences, a drug development and manufacturing accelerator that offers a range of integrated programs and tailored services to over 550 customers. Lewis discusses the latest developments in the delivery of oral peptides and how Quotient Sciences is helping customers overcome drug development challenges in this exciting space. 🔑HIGHLIGHTS// latest developments in the delivery of oral peptides Why have glucagon-like peptide-1 (GLP-1) therapies become essential for treating type 2 diabetes and obesity? What makes the oral delivery of peptides such as GLP-1 challenging? GLP-1 and gastric inhibitory polypeptide (GIP) are essential incretin hormones involved in regulating glucose metabolism. Both are produced in the gastrointestinal (GI) tract in response to food intake, specifically glucose and fats. GLP-1 enhances insulin secretion from the pancreas, but only in response to elevated blood glucose levels. GIP has overlapping effects that are slightly contradictory – it promotes the production of glucagon, which can counteract its glucose-lowering effects. In people with type 2 diabetes, the body’s response to incretin hormones is impaired. However, the GLP-1 pathway remains relatively intact, allowing it to still stimulate insulin production. There is a more significant impairment for GIP, making it not as effective. This makes GLP-1 a more attractive target for treatment, leading to the development of several GLP-1 receptor agonists for managing type 2 diabetes, obesity, and potentially other conditions. Incretin analogs, like GLP-1 agonists, have traditionally been challenging to deliver orally. As a result, these medications are most often given by injection. But we know that patients generally prefer taking a tablet or capsule treatment rather than an injection. Peptides such as GLP-1 analogs go through a challenging journey before being absorbed. This is because the gastrointestinal tract functions to digest these into either small amino acids or very short pieces of polypeptides. Even if they get to the epithelium, they tend to have poor permeability, usually resulting in less than 1 percent bioavailability (the proportion of a drug that enters the circulatory system when introduced into the body, thereby having an active effect). Various technologies have been developed to overcome bioavailability issues, with permeation enhancers being the most advanced and validated. For example, SNAC is the permeation enhancer used in Novo Nordisk’s oral pill Rybelsus to promote semaglutide absorption. Mycapssa (octreotide capsules), marketed by Chiesi, employs the Transient Permeation Enhancer (TPE) technology, which utilizes the medium-chain fatty acid (MCFA) sodium caprylate (C8) to augment the absorption of the somatostatin analog octreotide. At Quotient Sciences, over the last decade, we’ve worked on over 14 oral peptide programs and tested about a dozen different permeation enhancer combinations with them. Permeation enhancers tend to be required in large amounts in formulations, and many of them are usually waxy materials with poor flow, so the tablet formulation and manufacturing process require extra attention and careful design. From an analytics perspective, a lot of the standard quality control tests for tablets have been designed for small-molecule drugs and are yet to be optimized for use with peptides. 🔑HIGHLIGHTS// permeation enhancers as the most advanced and validated technology to overcome bioavailability issues/ worked on over 14 oral peptide programs/ tested about a dozen different permeation enhancer combinations How does Quotient Sciences handle the transition from pre-clinical to clinical development? We’ve pioneered an integrated approach through our Translational Pharmaceutics platform for drug development. This platform combines drug product manufacturing with clinical testing in healthy volunteers, allowing us to be incredibly adaptive in our phase I trial design. Through a tight integration of services, we can manufacture a drug, dose it in healthy volunteers, perform bioanalysis and pharmacokinetic analysis, and use data in real time to inform our next steps. In oral peptide programs, we’ve performed numerous studies where we’ve used this capability to optimize the formulation in response to the clinical data. Typical variables we’ve evaluated are the dose of the peptide and the levels of a permeation enhancer, allowing us to identify the relationship between them to maximize human bioavailability. Through our ability to see the full spectrum of data – from preclinical to clinical – for 11 different peptides and 10 different permeation enhancers, we have built up considerable expertise in the development of oral peptide drug products. This allows us to provide a more streamlined drug development process for our clients, as common challenges across programs can be readily overcome. 🔑HIGHLIGHTS// Translational Pharmaceutics platform for drug development/ combine drug product manufacturing with clinical testing in healthy volunteers/ use data in real time to inform next steps/ 11 different peptides and 10 different permeation enhancers What innovations do you see ahead for oral peptide delivery? I see a real convergence in advances in peptide drug discovery and engineering, together with advances in drug delivery that are really pushing the field forward. Technologies such as phage display mean that vast libraries of peptides can be screened for properties of interest. These are being applied to design peptides specifically for oral delivery. From a drug delivery perspective, approaches such as ingestible devices, ionic liquids and various technologies to exploit active uptake mechanisms are showing real promise. One challenge with oral peptide delivery technologies is that their effectiveness can be significantly impacted by food intake. However, I expect that in the coming years, new methods will be developed to mitigate these food-related effects. I also expect artificial intelligence (AI) to greatly benefit oral peptide delivery. In 2021, the US Food and Drug Administration reported it saw more than 100 drug and biologic application submissions containing elements of AI or machine learning (ML) used in the development process. So three to four years later, that number has likely only increased. All these developments promise to make oral peptide therapies more effective and convenient for patients in the years to come. 🔑HIGHLIGHTS// phage display to screen vast libraries of peptides for properties of interest/ ingestible devices, ionic liquids and various technologies to exploit active uptake mechanisms/ AI will greatly benefit oral peptide delivery To learn more about this topic, watch Quotient Sciences’ latest webinar featuring Dr. Andrew Lewis and Dr. Stuart Mair, Chief Medical Officer at Quotient Sciences. Watch it here.

    Impressions: 1098

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-have-built-considerable-expertise-in-glp-1-drug-development-through-our-oral-peptide-programs

    #SpeakPharma With Quotient Sciences
    14 Oct 2024
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Over the last few decades, the United States and Europe have saved trillions of dollars by importing drugs from countries like China and India. Their journey wasn’t easy, with regulatory non-compliance and drug patent scams raising their ugly heads every now and then. The Covid-19 pandemic and the accompanying lockdowns were a wake-up call for these countries to take a long, hard look at their sourcing strategies.Over the last few years, both the US and Europe have embarked on policy changes and ambitious programs to strengthen their drug supply chains. PharmaCompass takes you through US and Europe’s journeys towards more robust pharmaceutical supply chains.Biden’s executive order, CARES Act, state-backed investments strengthen US supply chainDuring the early days of the pandemic, the US government (under former President Donald Trump)  had enacted the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) to address the economic fallout of the pandemic through a US$ 2.2 trillion stimulus. Through this act, the FDA had taken several drug shortage mitigation efforts. The new administration under President Joe Biden undertook more measures. Notable amongst them was Executive Order 14017 on America’s supply chains. It mandated a comprehensive 100-day review to identify vulnerabilities in key sectors, including pharmaceuticals and active pharmaceutical ingredients (APIs). The review noted that 87 percent of generic API facilities are located overseas, leaving the US healthcare system vulnerable to shortages of essential medicines.Through a Presidential Determination, Biden had also broadened US Department of Health and Human Services’ (HHS) authorities under the Defense Production Act (DPA) of 1950. HHS can now enable investment in domestic manufacturing of essential medicines and medical countermeasures under the DPA. The HHS has invested US$ 17 billion in domestic manufacturing for the medical supply chain, including US$ 500 million to support API manufacturing.Under this effort, Merck has been awarded a €121 million (US$ 132 million) government contract to set up a lateral flow membrane production facility at Sheboygan, Wisconsin. Similarly, California has launched an initiative (known as CalRx) and is working with CIVICA to make US$ 30 insulin available to all who need it.Europe encourages reshoring; EDQM develops monographs for unlicensed alternativesIn recent years, Europe has faced shortages of insulin, antibiotics, oncology drugs, corticosteroids and even paracetamol. To overcome these shortages, the European Medicines Agency (EMA) is encouraging drugmakers to enhance manufacturing capacity and diversify suppliers.There is change visible on the ground. Companies like Midas Pharma, EUROAPI, Seqens are setting up API plants in Europe. Seqens has taken steps to reshore paracetamol production in France and is constructing a new € 100 million (US$ 109 million) production unit in Roussillon. Sanofi is investing €1.3 billion (US$ 1.4 billion) in a new insulin production facility at its existing site in Frankfurt. Similarly, Sandoz has set up a new antibiotic production plant in Austria and a new biosimilar development center in Germany.That said, we know that manufacturing capacities take time to build and are often financially unviable in the developed world. Ergo, a particularly innovative initiative has come from the European Directorate for the Quality of Medicines & HealthCare (EDQM). Their project aims to develop monographs detailing the preparation and testing of unlicensed drugs that can fill the gap left when licensed medicinal products are unavailable. To facilitate this initiative, the European Pharmacopoeia Commission is recruiting experts to verify proposed production methods and analytical procedures.The other means of guarding against supply and demand fluctuations is stockpiling. The EMA has advised the European Commission (EC) and marketing authorization holders (MAH) to stockpile medicines. The regulator has also asked MAHs to establish a shortage prevention plan for critical medicines. Europe’s Health Emergency Response Authority (HERA) is taking a systematic approach to stockpile management.Despite these measures, costs and market structures pose serious challenges. Medicines for Europe, representing the generic and biosimilar medicines industry, has raised concerns about the current market structures. They argue that government purchasing practices, which prioritize obtaining the lowest prices for off-patent medicines, are jeopardizing the European manufacturing footprint and discouraging investments in supply chain resilience.FDA, EMA promote continuous manufacturing; US relies on digital stockpilesDuring the pandemic, there were acute shortages of oncology, cardiovascular, anesthesia, anti-infective, neurological and anti-allergic drugs in the US. A 2022 study undertaken by the Washington University points out that there is excess manufacturing capacity in the US that can be considered for reshoring critical and essential drugs. In fact, 49 percent of generic drug manufacturing capacity in the US is lying idle, and many others are working at less than 50 percent capacity. These capacities can be repurposed. Various advanced manufacturing technologies, such as  “continuous flow and on-demand manufacturing capabilities in idled manufacturing sites offer the ability to reduce production cost,” says this report.FDA has been promoting “advanced manufacturing” technologies, such as continuous manufacturing, which are now a part of America’s overall strategy to strengthen and secure the pharmaceutical supply chain. The EMA has also released guidelines on continuous manufacturing of drug substances and drug products. Advanced manufacturing is a collective term for new or innovative medical product manufacturing technologies. Unlike batch manufacturing, which involves sequential processing and testing of material across multiple discrete stages (and often discrete facilities), continuous manufacturing combines the full manufacturing stream into a single, fully integrated flow. While continuous manufacturing may not be suitable for every drug manufacturing process, but where applicable, it tends to eliminate built-in production gaps and shortens the time taken to manufacture a drug from months to days.In the US, the Strategic National Stockpile (SNS) plays a critical role in ensuring the availability of essential medical supplies during emergencies. It now also involves a digital stockpile that does not store physical goods and products. Instead, it stores electronic plans, instructions, and methods to make and test medical products. Digital stockpiles rely on one or more trusted suppliers that can make the product from the digital information, either through methods like 3D printing or self-contained distributed manufacturing lines.Our viewThe global pharmaceutical supply chain is a complex web spanning multiple countries and continents. While advanced manufacturing and stockpiling may work to an extent, a large chunk of generic drugs and APIs will continue to come from countries like China and India.In order to reduce reliance on China, the US has been proactively expanding its collaboration with India. But this time, there is increased emphasis on quality control. While FDA is increasing the number of inspections at Indian drug plants, the Indian government, on its part, has revised rules for drug manufacturing, with higher GMP standards.Taken together, a multi-pronged approach to addressing supply chain vulnerabilities should secure drug supplies to the US and Europe in the years to come.  
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 472

    https://www.pharmacompass.com/radio-compass-blog/us-europe-turn-to-advanced-manufacturing-stockpiling-to-strengthen-drug-supply-chains

    #Phispers by PHARMACOMPASS
    17 Oct 2024
    Share Share

    NEWS #PharmaBuzz

    read-more
    read-more
    Eylea 8 mg Efficacy In Diabetic Macular Edema Confirmed At Three Years
    Eylea 8 mg Efficacy In Diabetic Macular Edema Confirmed At Three Years

    19 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/long-term-efficacy-and-safety-profile-of-eylea-8-mg-with-extended-dosing-intervals-in-diabetic-macular-edema-confirmed-at-three-years-16338

    INDPHARMAPOST
    19 Oct 2024
    Share Share
    Bayer submits EU marketing application for menopause relief drug
    Bayer submits EU marketing application for menopause relief drug

    15 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-submits-eu-marketing-application-menopause-relief-drug-2024-10-15/

    REUTERS
    15 Oct 2024
    Share Share
    Bayer applies for third indication of Nubeqa in EU
    Bayer applies for third indication of Nubeqa in EU

    14 Oct 2024

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/bayer-applies-third-indication-nubeqa-eu-2024-10-14/

    REUTERS
    14 Oct 2024
    Share Share
    Orion's Partner Bayer Submits Application For Darolutamide
    Orion's Partner Bayer Submits Application For Darolutamide

    14 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/14/2962356/0/en/Orion-s-collaboration-partner-Bayer-submits-application-for-third-indication-of-darolutamide-in-the-EU.html

    GLOBENEWSWIRE
    14 Oct 2024
    Share Share
    Bayer must pay $78 million in latest Roundup cancer trial, jury finds
    Bayer must pay $78 million in latest Roundup cancer trial, jury finds

    11 Oct 2024

    // REUTERS

    https://www.reuters.com/legal/bayer-must-pay-78-mln-latest-roundup-cancer-trial-jury-finds-2024-10-10/

    REUTERS
    11 Oct 2024
    Share Share
    US judicial panel to examine litigation finance disclosure
    US judicial panel to examine litigation finance disclosure

    10 Oct 2024

    // REUTERS

    https://www.reuters.com/legal/government/us-judicial-panel-examine-litigation-finance-disclosure-2024-10-10/

    REUTERS
    10 Oct 2024
    Share Share

    USDMF

    read-more
    read-more

    01

    5-aminosalicylic Acid

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    02

    6-methylprednisolne

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    03

    6-methylprednisolone-21-hemisuccinat...

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    04

    6a-methylprednisolone-21-acetate

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    05

    Acarbose

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    06

    Acemetacin

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    07

    Acetylsalicylic Acid (aspirin)

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    08

    Alclometasone Dipropionate, Usp

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    09

    Amidotrizoic Acid (urografin Acid)

    Germany
    AAPS 2024
    Not Confirmed
    arrow

    10

    Ampicillin

    Germany
    AAPS 2024
    Not Confirmed
    arrow
    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Contact Bayer AG and get a quotation

    Bayer AG is a supplier offers 150 products (APIs, Excipients or Intermediates).

    Find a price of Ethinyl Estradiol bulk with DMF, CEP, JDMF offered by Bayer AG

    Find a price of Iopromide bulk with DMF, CEP, JDMF offered by Bayer AG

    Find a price of Levonorgestrel bulk with DMF, CEP, JDMF offered by Bayer AG

    Find a price of Norethisterone bulk with CEP, JDMF offered by Bayer AG

    Find a price of Acarbose bulk with DMF, CEP offered by Bayer AG

    Find a price of CAS 50-28-2 bulk with DMF, JDMF offered by Bayer AG

    Find a price of Ciprofloxacin bulk with DMF, CEP offered by Bayer AG

    Find a price of Ciprofloxacin Hydrochloride bulk with DMF, CEP offered by Bayer AG

    Find a price of Clotrimazole bulk with DMF, CEP offered by Bayer AG

    Find a price of Drospirenone bulk with DMF, CEP offered by Bayer AG

    Find a price of Estradiol bulk with DMF, CEP offered by Bayer AG

    Find a price of Gadobutrol bulk with DMF, CEP offered by Bayer AG

    Find a price of Medroxyprogesterone Acetate bulk with DMF, CEP offered by Bayer AG

    Find a price of Mesalazine bulk with JDMF offered by Bayer AG

    Find a price of Norethisterone bulk with DMF, CEP offered by Bayer AG

    Find a price of Norethisterone Acetate bulk with DMF, CEP offered by Bayer AG

    Find a price of Rivaroxaban bulk with DMF, CEP offered by Bayer AG

    Find a price of Testosterone bulk with DMF, CEP offered by Bayer AG

    Find a price of Testosterone Enanthate bulk with DMF, CEP offered by Bayer AG

    Find a price of Aprotinin bulk with DMF offered by Bayer AG

    Find a price of Aspirin bulk with CEP offered by Bayer AG

    Find a price of Cyproterone Acetate bulk with CEP offered by Bayer AG

    Find a price of Diflucortolone Valerate bulk with JDMF offered by Bayer AG

    Find a price of Estriol bulk with CEP offered by Bayer AG

    Find a price of Etofenamate bulk with CEP offered by Bayer AG

    Find a price of Gestodene bulk with CEP offered by Bayer AG

    Find a price of Hydrocortisone bulk with CEP offered by Bayer AG

    Find a price of Nifedipine bulk with CEP offered by Bayer AG

    Find a price of Testosterone bulk with CEP offered by Bayer AG

    Find a price of Acemetacin bulk offered by Bayer AG

    Find a price of Alpha-Cyclodextrin bulk with DMF offered by Bayer AG

    Find a price of Azelaic Acid bulk with DMF offered by Bayer AG

    Find a price of CAS 50-28-2 bulk with DMF offered by Bayer AG

    Find a price of Ciprofloxacin bulk with DMF offered by Bayer AG

    Find a price of Dienogest bulk with DMF offered by Bayer AG

    Find a price of Estradiol Valerate bulk with CEP offered by Bayer AG

    Find a price of Gadolinium Ethoxybenzyl Dtpa bulk with DMF offered by Bayer AG

    Find a price of Iloprost bulk with DMF offered by Bayer AG

    Find a price of Iopromide bulk with CEP offered by Bayer AG

    Find a price of Levonorgestrel bulk with DMF offered by Bayer AG

    Find a price of Molidustat bulk with DMF offered by Bayer AG

    Find a price of Moxifloxacin Hydrochloride bulk with CEP offered by Bayer AG

    Find a price of Nisoldipine bulk with DMF offered by Bayer AG

    Find a price of Norethisterone bulk with CEP offered by Bayer AG

    Find a price of Rivaroxaban bulk with DMF offered by Bayer AG

    Find a price of Testosterone Undecanoate bulk with DMF offered by Bayer AG

    Find a price of 5-Hydroxy Tryptophan bulk offered by Bayer AG

    Find a price of Agar bulk offered by Bayer AG

    Find a price of Alclometasone Dipropionate bulk offered by Bayer AG

    Find a price of Allopregnanolone bulk offered by Bayer AG

    Find a price of Amidotrizoic Acid bulk offered by Bayer AG

    Find a price of Ampicillin bulk offered by Bayer AG

    Find a price of Ampicillin Sodium bulk offered by Bayer AG

    Find a price of Ampicillin Trihydrate bulk offered by Bayer AG

    Find a price of Asoprisnil bulk offered by Bayer AG

    Find a price of Aspirin bulk offered by Bayer AG

    Find a price of Atamestane bulk offered by Bayer AG

    Find a price of Bay Y3118 bulk offered by Bayer AG

    Find a price of Beta-Cyclodextrin API bulk offered by Bayer AG

    Find a price of Betamethasone bulk offered by Bayer AG

    Find a price of Betamethasone Valerate bulk offered by Bayer AG

    Find a price of Bifonazole bulk offered by Bayer AG

    Find a price of Boldenone Undecylenate bulk offered by Bayer AG

    Find a price of CAS 53-16-7 bulk offered by Bayer AG

    Find a price of Ciprofloxacin bulk offered by Bayer AG

    Find a price of Clocortolone Acetate bulk offered by Bayer AG

    Find a price of Cyproterone Acetate bulk offered by Bayer AG

    Find a price of Danazol bulk offered by Bayer AG

    Find a price of Deflazacort bulk offered by Bayer AG

    Find a price of Entinostat bulk offered by Bayer AG

    Find a price of Estradiol Enanthate bulk offered by Bayer AG

    Find a price of Ethinamate bulk offered by Bayer AG

    Find a price of Fludarabine Phosphate bulk offered by Bayer AG

    Find a price of Fluocortin Butyl Ester bulk offered by Bayer AG

    Find a price of Gentamicin Sulfate bulk offered by Bayer AG

    Find a price of Hyaluronic Acid bulk offered by Bayer AG

    Find a price of Hydrocortisone Acetate bulk offered by Bayer AG

    Find a price of Hydrocortisone Sodium Succinate bulk offered by Bayer AG

    Find a price of Hydroxyprogesterone Caproate bulk offered by Bayer AG

    Find a price of Iloprost bulk offered by Bayer AG

    Find a price of Iotrolan bulk offered by Bayer AG

    Find a price of Ipodate bulk offered by Bayer AG

    Find a price of Isoniazid bulk offered by Bayer AG

    Find a price of Levonorgestrel bulk offered by Bayer AG

    Find a price of Lisuride bulk offered by Bayer AG

    Find a price of Lisuride Maleate bulk offered by Bayer AG

    Find a price of Lormetazepam bulk offered by Bayer AG

    Find a price of Megestrol Acetate bulk offered by Bayer AG

    Find a price of Meglumine bulk offered by Bayer AG

    Find a price of Mesterolone bulk offered by Bayer AG

    Find a price of Mestranol bulk offered by Bayer AG

    Find a price of Methyl Testosterone bulk offered by Bayer AG

    Find a price of Methylprednisolone bulk offered by Bayer AG

    Find a price of Methylprednisolone Acetate bulk offered by Bayer AG

    Find a price of Methylprednisolone Hemisuccinate bulk offered by Bayer AG

    Find a price of Muzolimine bulk offered by Bayer AG

    Find a price of Nandrolone Decanoate bulk offered by Bayer AG

    Find a price of Nandrolone Phenpropionate bulk offered by Bayer AG

    Find a price of Niclosamide bulk offered by Bayer AG

    Find a price of Nifedipine bulk offered by Bayer AG

    Find a price of Nimodipine bulk offered by Bayer AG

    Find a price of Nitrendipine bulk offered by Bayer AG

    Find a price of Norethisterone Enanthate bulk offered by Bayer AG

    Find a price of Onapristone bulk offered by Bayer AG

    Find a price of Pancuronium Bromide bulk offered by Bayer AG

    Find a price of Paracetamol bulk offered by Bayer AG

    Find a price of Pentetic Acid bulk offered by Bayer AG

    Find a price of Pirazolac bulk offered by Bayer AG

    Find a price of Prednisolone bulk offered by Bayer AG

    Find a price of Prednisolone Acetate bulk offered by Bayer AG

    Find a price of Prednisolone Sodium Phosphate bulk offered by Bayer AG

    Find a price of Prednisone bulk offered by Bayer AG

    Find a price of Quinestrol bulk offered by Bayer AG

    Find a price of Quinidine Gluconate bulk offered by Bayer AG

    Find a price of Radium-224 bulk offered by Bayer AG

    Find a price of Rolipram bulk offered by Bayer AG

    Find a price of Spironolactone bulk offered by Bayer AG

    Find a price of Sulfasalazine bulk offered by Bayer AG

    Find a price of Sulfathiazole Sodium bulk offered by Bayer AG

    Find a price of Testosterone Propionate bulk offered by Bayer AG

    Find a price of Trichlorfon bulk offered by Bayer AG

    Find a price of Water bulk offered by Bayer AG

    Find a price of GENERAL OPERATING PROCEDURE bulk offered by Bayer AG

    Find a price of FACIL, PERSONNEL & GEN OPERATING PROCEDS FOR MANATI, PR PLANT bulk offered by Bayer AG

    Find a price of ZK807834 bulk offered by Bayer AG

    Find a price of EOB-DTPA bulk offered by Bayer AG

    Find a price of DROXONE bulk offered by Bayer AG

    Find a price of FACILITY AND OPERATING PROCEDURES IN DORMAGEN, WEST GERMANY bulk offered by Bayer AG

    Find a price of ULTRALANUM CREAM PLAIN bulk offered by Bayer AG

    Find a price of FACILITIES AND PERSONNEL IN LEVERKUSEN, GERMANY bulk offered by Bayer AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN POINTE CLAIRE, QUEBEC. bulk offered by Bayer AG

    Find a price of GENERAL OPERATING PROCEDURES bulk offered by Bayer AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES. bulk offered by Bayer AG

    Find a price of GENERAL OPERATING PROCEDURES FOR BULK PRODUCTS bulk offered by Bayer AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL AND PROCEDURES IN WEIMAR, GERMANY bulk offered by Bayer AG

    Find a price of HYDROXY ACID bulk offered by Bayer AG

    Find a price of ZK 112 119(6-BOCIP) bulk offered by Bayer AG

    Find a price of BOVINE THROMBIN bulk offered by Bayer AG

    Find a price of THE COMPLETE BUTYL PRODUCT LINE bulk offered by Bayer AG

    Find a price of 17 ALPHA-ETHINYL-19-NOR-TESTOSTERONE bulk offered by Bayer AG

    Find a price of FACILITIES FOR THE MFG OF LIQUID & SOFT GELATIN CAPSULE PRODUCTS bulk offered by Bayer AG

    Find a price of GEN. OPERATING PROCEDS FOR BULK PRODUCTS-SCHERING AG BERGKAMEN PLANT bulk offered by Bayer AG

    Find a price of PYNASUNATE bulk offered by Bayer AG

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GARBAGNATE MILANESE ITALY. bulk offered by Bayer AG

    Find a price of FACILITY IN DARDILLY, FRANCE bulk offered by Bayer AG

    Find a price of MFG. AND CONTROL OF CLINICAL SUPPLIES IN BERLIN, W. GERMANY bulk offered by Bayer AG

    Find a price of FACILITIES AND PERSONNEL AT WUPPERTAL, WEST GERMANY bulk offered by Bayer AG

    Find a price of 17A-ETHINYL-19-NOR-TESTOSTERONE ACETATE bulk offered by Bayer AG

    Find a price of Fluocortolone Caproate bulk offered by Bayer AG

    Find a price of Fluocortolone Pivalate bulk offered by Bayer AG

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search